微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.33% | -61.45% | -14.19% | 95/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.55% | 21.09% | -55.46% | 69/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 3.48% | 68.12% | -22.84% | 75/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 4.51% | -29.86% | 30.72% | 66/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.45% | 28.25% | 169.53% | 56/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.28% | -0.78% | -38.16% | 72/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.07% | 131.46% | -67.81% | 87/157 | -9.62% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 6.43% | 464.04% | 139.03% | 56/157 | 4.28% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.69% | 326.98% | 108.53% | 68/157 | 2.69% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.29% | 138.89% | 119.6% | 83/157 | 2.35% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -6.58% | -204.44% | -677.19% | 121/157 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 1.14% | -79.23% | 80.95% | 107/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.63% | -85.31% | 16.67% | 108/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.54% | -73.53% | -91.43% | 107/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 6.3% | 707.69% | 14.75% | 63/157 | 0.79% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 5.49% | 38.64% | 27.97% | 60/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 4.29% | 75.82% | 110.29% | 56/157 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.04% | 65.85% | 161.54% | 58/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 0.78% | -87.98% | -80.3% | 111/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 3.96% | -53.3% | 62.3% | 87/157 | 4.46% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.44% | -63.47% | 98.37% | 90/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.23% | -63.82% | -81.05% | 87/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 6.49% | -2.26% | -23.47% | 75/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.48% | -18.54% | 26.95% | 44/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 6.68% | 542.31% | 96.47% | 38/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 3.4% | -57.5% | -48.8% | 26/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 6.64% | 4.73% | -36.22% | 76/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.41% | 68.45% | 900.96% | 33/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.04% | -62.18% | -87% | 96/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 8% | 809.09% | 26.18% | 4/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.34% | 1096.23% | 2.59% | 73/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.18% | 505.88% | 124.73% | 52/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.75% | 5600% | 212.5% | 71/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.88% | 686.67% | 66.04% | 81/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 0.53% | -84.99% | -48.04% | 112/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.02% | -72.28% | 2140% | 90/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | -0.05% | -102.21% | 66.67% | 99/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -0.15% | -106.61% | -104.25% | 81/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 3.53% | -44.5% | -4.08% | 87/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.68% | -26.98% | 62.83% | 61/157 | 5.64% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 2.26% | -28.03% | -0.44% | 66/157 | 3.52% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.27% | 2.71% | -64.31% | 36/157 | 2.69% | 贝达药业 | 16.78% | 行业排名> |